BIOHIT Appoints Market Access & Development Manager

March 27, 2024

BIOHIT HealthCare Ltd are pleased to announce the appointment of Angela Gore as Market Access & Development Manager.

Following a successful few years of growth at BIOHIT, this announcement sees the expansion of the BIOHIT team. This new role will focus on developing networks within the NHS, improving the exposure of BIOHIT’s key products, and broadening the company’s market reach into new areas.

Angela brings with her over 30 years’ experience in the diagnostics industry. Having studied Biomedical Science her career path has provided her with extensive knowledge in autoimmunity. Although not a brand-new face to BIOHIT, Angela previously worked at the company, before leaving to pursue commercial roles in well known diagnostic organisations such as Quidel. She now returns with a fresh outlook and enthusiasm to drive forward the growth of the business in her new role.

Graham Johnson, Managing Director of BIOHIT HealthCare Ltd announced “We are extremely happy to welcome Angela back to the team. Having previously worked alongside her, I am confident in her abilities to collaborate with industry experts and elevate the awareness of our product portfolio, and I know she will play a pivotal role in the growth story of our organisation”.

Angela added, “Stepping back into BIOHIT shoes has been gratifying. I’ve already reconnected with old friends and colleagues and introduced new contacts to BIOHIT. It’s an exciting time to rejoin the team, and I’m most looking forward to introducing our groundbreaking products, such as GastroPanel®, Peptest and our range of SmarTest®’s to industry experts across the country.”

Angela will be attending various events and conferences throughout the year and will be open to discussions around collaborations and partnering opportunities with BIOHIT’s product portfolio. If you’d like to arrange a meeting at any of BIOHIT’s upcoming events visit: https://biohithealthcare.co.uk/about/events/


About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

Recent Posts

Connecting IBD care at University Hospital Southampton

December 4, 2025

Improving paediatric reflux care with objective, non-invasive diagnostics

November 18, 2025
SmarTest Calprotectin Home Test

SmarTest® faecal calprotectin home testing in practice: lessons from leading UK IBD clinics

September 10, 2025

Expanding access to gastrointestinal diagnostics: the role of community diagnostic centres and point of care testing

June 24, 2025